Johnson & Johnson Innovative Medicine

We’re restoring the true meaning of healthcare—developing advanced treatments and smarter and less invasive solutions for today’s most complex diseases. See how we're connecting the best of Health&Care for every patient and provider. https://lnkd.in/eW-mXA49

We are honored to have been nominated by The Galien Foundation for four awards recognizing our broad and innovative oncology pipeline. Learn more about the #PrixGalien USA Awards: https://prn.to/4ftw4Xh #JNJOncology

At Johnson & Johnson, we’re committed to better understanding neuropsychiatric disorders and advancing research and innovation that can help positively impact patients’ lives. That’s why we’re looking forward to presenting a multitude of new study findings and analyses at Psych Congress, including a poster detailing the link between schizophrenia symptom relapse and risk of death, which can occur 15-20 years prematurely for adults living with schizophrenia compared to the general population due to many different causes. Learn more about the data we’re presenting this week: https://bit.ly/3AmMPVa #PsychCongress2024 #Depression #Schizophrenia #MentalHealth #Neuroscience

Inflammatory bowel disease (#IBD) is commonly considered an “invisible disease,” often leaving patients feeling isolated and misunderstood – but no one should feel alone in their IBD journey.     That’s why, ten years ago, we created IBD Social Circle (IBDSC) in partnership with IBD advocates to bring this community together and shed light on the realities of living with IBD.      In the last decade, we have achieved many milestones led by IBD advocates, from tackling conversations on real-life IBD topics to sharing resources for people at any phase of their IBD journey. Through it all, our commitment to this community has continued to grow stronger, and we’re looking forward to all that the next decade may hold.     Learn more about IBD Social Circle: https://lnkd.in/ebUz8vtz 

Despite recent scientific progress, #LungCancer continues to be an area of critical unmet need. That’s why we are determined to transform the future of this disease through groundbreaking innovation and science: https://bit.ly/4f9xsyk #JNJOncology #LungCancerAwarenessMonth

Biologic coordinators are essential members of a patient care team – yet many people may not realize it. Today, on #NationalBiologicCoordinatorsDay, we’re working to change that. For people with immune-mediated diseases who may be juggling multiple prescriptions, navigating insurance and specialty pharmacies, and keeping track of a variety of medical appointments, a biologic coordinator can be a critical partner in managing it all. Inflammatory bowel disease (IBD) advocate Jaime Holland shares why a biologic coordinator is an important part of her care team and how she partners with them to advocate for her care. #JNJImmunology #BiologicCoordinator

"Getting in front of cancer means changing the status quo.” Johnson & Johnson’s Joshua Bauml, M.D., Vice President, Lung Cancer Disease Area Stronghold Leader, shares his commitment to getting #InFrontofCancer by advancing treatment options for the world’s leading cause of cancer mortality. This #LungCancerAwarenessMonth, join us in raising awareness about the urgent need to advance new standards of care for this disease: https://bit.ly/3UxyOuO #JNJOncology

Over the last few days, we had the privilege of presenting important new data at #ACG2024. The groundbreaking findings showcased our expertise and innovative methods in treating inflammatory bowel disease. As we strive to develop new treatments that offer choices and flexibility for patients and providers, we are deeply grateful for the opportunity to present at #ACG2024. This event provided an invaluable platform, bringing together scientists, researchers, and experts committed to enhancing the lives of patients with digestive diseases. #JNJImmunology

Are you heading to the American College of Rheumatology Annual Meeting?  Join us for an evening reception on November 15th focused on next-generation therapies for rheumatic diseases.     Attendees will have the opportunity to network with like-minded innovators and industry leaders as we exchange ideas on advancing the next-generation of therapeutics for patients. Johnson & Johnson Innovative Medicine leaders will showcase our priorities for collaborating in this rapidly growing space.   RSVP today: https://lnkd.in/e84MCkz9 

Behind every breakthrough is a leader like Afia Afzal, whose passion for data science and personal commitment to diversity fuel our innovation. 💡Afia is using AI to identify clinical trial sites with a high likelihood of enrolling diverse patients. She’s ensuring our research is reflective of all patients impacted by the diseases we’re tackling. That’s leading where medicine is going. #DataScience #Innovation #JNJ https://lnkd.in/e_fWxkiY